CD274 and cancer: However, the chemo-immuno combination therapy may have the most promising future for further clinical translation considering that immunotherapy using PD-1/PD-L1 antibodies, CTAL-4 antibodies and CAR-T treatment has been recently revealed as a powerful clinical strategy for treating cancer.